Post-COVID-19 condition in patients with autoimmune rheumatic diseases: the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study

Lancet Rheumatol. 2023 May;5(5):e247-e250. doi: 10.1016/S2665-9913(23)00066-8. Epub 2023 Apr 24.

Parikshit Sen¹, Naveen R², Arvind Nune³, Jessica Day^{4

5

6}, Mrudula Joshi⁷, Vikas Agarwal², Rohit Aggarwal⁸, Latika Gupta^{9

10

11}; COVAD study group

¹ Maulana Azad Medical College, New Delhi, India.
² Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
³ Southport and Ormskirk Hospital NHS Trust, Southport, UK.
⁴ Department of Rheumatology, Royal Melbourne Hospital, Parkville, VIC, Australia.
⁵ Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
⁶ Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
⁷ Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals, Pune, India.
⁸ Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
⁹ Department of Rheumatology, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton WV10 0QP, UK.
¹⁰ Division of Musculoskeletal and Dermatological Sciences, Centre for Musculoskeletal Research, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
¹¹ City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.

No abstract available